| |
| The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors. |
| |
|
|
| Abstract Details |
 |
|
| |
| |
| |
|
|
| |
Managing Viral Hepatitis C: HCV: New Opportunities, High CostTwo new biologics establish a higher standard of care. Managing these agents, however, will be highly complex |
|
|
|
|
| |
Cawood J. Biotechnol Healthc. 2011 Fall;8(3):26-8. |
|
| |
|
|
| |
Abstract - Two new biologics for HCV present treatment and cost-management challenges.
|
|
|
|
| |
| |
|
